Endothelial Dysfunctions and Vascular Disease gathers all the latest information on the subject into one convenient and cohesive text.
Endothelial Dysfunctions and Vascular Disease features:
- endothelial activation and the initiation of atherosclerosis
- mechanisms of plaque progression and complications
- the role of LDL in the origin and progression of atherosclerosis
- advanced glycation endproducts and the accelerated atherosclerosis in diabetes
- oxidative stress and vascular disease
- soluble adhesion molecules as markers of vascular disease
- hormone-replacement therapy and cardiovascular risk
- anti-oxidants and endothelial protection
Contents
The basis of endothelial involvement in vascular diseases
- Endothelial functions and dysfunctions
- Endothelial activation and the initiation of atherosclerosis
- Mechanisms of plaque progression and complications
- Angiogenesis in cardiovascular disease
The endothelium and cardiovascular risk factors
- VLDL and atherosclerosis
- High-density lipoprotein and atheroprotection
- Advanced glycation endproducts and the accelerated atherosclerosis in diabetes
- Homocysteine and endothelial dysfunction
- Lipoprotein(a) and the artery wall
- Oxidative stress and vascular disease
- Infections and vascular disease
Diagnostic tools and markers of endothelial functions
- Endothelial vasodilatory dysfunction: basic concepts and practical implementation
- Endothelial vasodilatory dysfunction and risk factors in adults
- Endothelial vasodilatory dysfunction in early life
- Endothelial vasodilatory dysfunction in hypertension
- Vascular function and diabetes mellitus
- Dyslipidemia and endothelial dysfunction: pathophysiology and therapy
- Soluble adhesion molecules as in vivo biohumoral markers of vascular cell activation
Endothelium-directed prevention and therapy
- Hormone replacement therapy and cardiovascular disease
- Anti-atherogenic effects of omega-3 fatty acids
- Treatment of endothelial dysfunction and atherosclerosis by cholesterol lowering
- Antioxidants and endothelial protection
- Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers to reverse endothelial dysfunction
- PPARs in atherosclerosis
- Stem cells in atherosclerosis and atherosclerosis-related vascular disorders
- Endothelium-targeted gene and cell-based therapy for cardiovascular disease
Index
to see books of related interest